Stereotaxis Inc

NYSE MKT:STXS USA Medical Instruments & Supplies
Market Cap
$176.38 Million
Market Cap Rank
#17289 Global
#6571 in USA
Share Price
$1.89
Change (1 day)
-1.05%
52-Week Range
$1.60 - $3.57
All Time High
$10.17
About

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as the Genesis RMN, which enable physicians to complete interventional procedures by providing image-guided delivery of catheters and guidewires thro… Read more

Stereotaxis Inc (STXS) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: -0.364x

Based on the latest financial reports, Stereotaxis Inc (STXS) has a cash flow conversion efficiency ratio of -0.364x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.20 Million) by net assets ($11.53 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Stereotaxis Inc - Cash Flow Conversion Efficiency Trend (2002–2024)

This chart illustrates how Stereotaxis Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Stereotaxis Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Stereotaxis Inc ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Stereotaxis Inc (2002–2024)

The table below shows the annual cash flow conversion efficiency of Stereotaxis Inc from 2002 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $11.43 Million $-8.50 Million -0.743x -78.27%
2023-12-31 $21.92 Million $-9.14 Million -0.417x -58.19%
2022-12-31 $31.93 Million $-8.41 Million -0.264x -252.70%
2021-12-31 $39.42 Million $-2.95 Million -0.075x +14.40%
2020-12-31 $40.23 Million $-3.51 Million -0.087x +46.06%
2019-12-31 $28.52 Million $-4.62 Million -0.162x +53.78%
2018-12-31 $7.27 Million $-2.55 Million -0.350x -254.38%
2017-12-31 $-20.61 Million $-4.67 Million 0.227x -46.32%
2016-12-31 $-15.53 Million $-6.56 Million 0.423x +194.59%
2015-12-31 $-17.63 Million $-2.53 Million 0.143x -80.20%
2014-12-31 $-12.55 Million $-9.09 Million 0.724x +33.90%
2013-12-31 $-11.70 Million $-6.33 Million 0.541x -16.10%
2012-12-31 $-18.79 Million $-12.12 Million 0.645x -61.54%
2011-12-31 $-18.83 Million $-31.57 Million 1.677x +192.88%
2010-12-31 $10.48 Million $-18.91 Million -1.805x +38.17%
2009-12-31 $7.64 Million $-22.31 Million -2.919x +51.39%
2008-12-31 $4.77 Million $-28.65 Million -6.006x -306.91%
2007-12-31 $24.19 Million $-35.71 Million -1.476x -69.60%
2006-12-31 $44.79 Million $-38.98 Million -0.870x +61.51%
2005-12-31 $18.13 Million $-40.99 Million -2.261x -315.04%
2004-12-31 $58.39 Million $-31.81 Million -0.545x +43.74%
2003-12-31 $25.27 Million $-24.47 Million -0.968x -5.54%
2002-12-31 $24.01 Million $-22.03 Million -0.918x --